Akebia Therapeutics (NASDAQ: AKBA) reported Q3 net loss of $59.5M. Revenue for the quarter came in at $48.8 million versus the consensus estimate of $49.67 million.

For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.